Stock Markets July 14, 2026 02:57 PM

Options Point to 4.2% Move for MSCI Ahead of July 21 Results

Options-implied volatility suggests a modest swing; stock has outpaced implied moves in five of the last eight reporting periods

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MSCI

Options pricing implies MSCI Inc. stock could move about 4.2% when the company reports earnings before the market opens on July 21, based on options data compiled by Bloomberg. Historically, MSCI has moved by more than the options-implied amount in five of its last eight earnings announcements, with several notable outsized reactions listed below.

Options Point to 4.2% Move for MSCI Ahead of July 21 Results
MSCI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Options-implied move is 4.2% for July 21 pre-market earnings
  • MSCI exceeded implied moves in five of its last eight earnings reports
  • Impacts financial-data providers and options-based trading strategies

Options market pricing indicates MSCI Inc. may experience a 4.2% price move when it reports quarterly results before the market opens on July 21, according to options data compiled by Bloomberg.

Investors and traders often look to options-implied moves as a consensus gauge of expected volatility around earnings. In MSCI’s case, the options market is pricing in a roughly 4.2% absolute move in the stock price for the upcoming release.

Looking back across recent reporting periods, MSCI’s actual stock moves have frequently exceeded the options-implied figures. In five of the company’s last eight earnings announcements the stock swung by a greater amount than the options market had implied. Key past results include:

  • On April 21, 2026, MSCI stock moved 8.1% compared to an implied move of 4.9%.
  • On January 28, 2026, the stock moved 5.2% against an implied move of 3.8%.
  • On October 28, 2025, the stock moved 10.6% compared to an implied move of 4.4%.
  • On July 22, 2025, the stock fell 7.7% against an implied move of 5.9%.
  • On April 22, 2025, the stock declined 2.3% compared to an implied move of 5.8%.
  • On January 29, 2025, the stock dropped 3.9% against an implied move of 6.2%.
  • On October 29, 2024, the stock fell 4.1% compared to an implied move of 5.3%.
  • On July 23, 2024, the stock rose 8.9% against an implied move of 4.5%.

Those results illustrate that actual stock reactions around MSCI earnings have at times been meaningfully larger than what options-implied volatility suggested. Market participants monitoring this upcoming release will likely weigh the options-implied 4.2% figure against MSCI’s historical tendency for occasional outsized moves.


Summary: Options pricing implies a 4.2% absolute move for MSCI when it reports before the market opens on July 21. In five of the last eight earnings releases, MSCI’s stock swing exceeded the options-implied move, with several episodes of double-digit or high-single-digit reactions.

Key points:

  • Options-implied move for July 21 earnings: 4.2% (pre-market release).
  • MSCI outpaced the options-implied move in five of its past eight earnings announcements.
  • Sectors affected include financial data and analytics, and broader equity market trading strategies that use options to hedge earnings risk.

Risks and uncertainties:

  • Options-implied moves are a consensus expectation and may under- or over-state the actual stock reaction to earnings, affecting traders in options and equity markets.
  • Past instances of outsized stock moves indicate potential volatility for investors in MSCI and related financial data and index-related services.
  • The historical pattern does not guarantee similar outcomes for the upcoming report; actual results may diverge from implied expectations.

Risks

  • Options-implied moves may not reflect actual post-earnings price action, affecting options and equity traders
  • Historical volatility around earnings signals potential for sharp moves in MSCI stock and related sectors
  • Past behavior does not ensure the same reaction in the upcoming report

More from Stock Markets

Writers Guild Files Suit to Halt Paramount's $110 Billion Deal, Saying It Would Weaken Competition for Screenwriters Jul 14, 2026 Stifel Elevates Lumentum as Top Near-Term Pick in Optical Components Jul 14, 2026 FDA Clears Celcuity’s Gedatolisib, Marking Company's First Marketed Therapy Jul 14, 2026 Celcuity Shares Rally as FDA Decision on Gedatolisib Looms Jul 14, 2026 House Democrat Asks Paramount CEO If CBS Is Being Pressured to Run Pro-Trump Material Jul 14, 2026